TAM
ACOR

Tyers Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Tyers Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-54
Closed -$50K – 1024
2019
Q2 		$50K Buy
54
+12
+29% +$14.7K ﹤0.01% 929
2019
Q1 		$66K Hold
42
– – ﹤0.01% 890
2018
Q4 		$78K Hold
42
– – ﹤0.01% 838
2018
Q3 		$98K Hold
42
– – ﹤0.01% 874
2018
Q2 		$143K Hold
42
– – ﹤0.01% 782
2018
Q1 		$118K Hold
42
– – ﹤0.01% 817
2017
Q4 		$107K Buy
42
+15
+56% +$42.6K ﹤0.01% 842
2017
Q3 		$76K Buy
27
+5
+23% +$13.2K ﹤0.01% 870
2017
Q2 		$52K Buy
22
+10
+83% +$19.8K ﹤0.01% 913
2017
Q1 		$29K Buy
12
+1
+9% +$2.88K ﹤0.01% 918
2016
Q4 		$25K Buy
+11
New +$26.2K ﹤0.01% 893

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tyers Asset Management's ACOR Position: Q3 2019 in Review

Tyers Asset Management sold out of Acorda Therapeutics (ACOR) in Q3 2019, closing a stake of 54 shares — an estimated $50K sold.

Tyers Asset Management first reported a position in ACOR in Q4 2016 and held it in 11 quarters. The position peaked at $143K in Q2 2018. 151 funds tracked by Wall St. Rank hold ACOR as of Q3 2019.

  • Tyers Asset Management reported no remaining Acorda Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Tyers Asset Management sold 54 Acorda Therapeutics shares in Q3 2019, an estimated $50K.
  • Tyers Asset Management first reported a position in Acorda Therapeutics in Q4 2016 and held it in 11 quarters.
  • Tyers Asset Management's Acorda Therapeutics position peaked at $143K in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.